Letrozole Accord Healthcare 2,5 mg film-coat. tabl.

País: Bélgica

Idioma: inglés

Fuente: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes activos:

Letrozole 2,5 mg

Disponible desde:

Accord Healthcare B.V.

Código ATC:

L02BG04

Designación común internacional (DCI):

Letrozole

Dosis:

2,5 mg

formulario farmacéutico:

Film-coated tablet

Composición:

Letrozole 2.5 mg

Vía de administración:

Oral use

Área terapéutica:

Letrozole

Resumen del producto:

CTI code: 347146-09 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-08 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-10 - Pack size: 100 - Commercialisation status: NO - CNK code: 2926921 - Delivery mode: Medical prescription; CTI code: 347146-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-03 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-02 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-05 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-04 - Pack size: 30 - Commercialisation status: NO - CNK code: 2950764 - Delivery mode: Medical prescription; CTI code: 347146-07 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 347146-06 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription

Estado de Autorización:

Commercialised: No

Fecha de autorización:

2009-09-10